Delivery Order SPE2DE24D0013-SPE2D626F36RD
- Not listed
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,277.84 to Cepheid Inc. (Sunnyvale, CA) on January 14, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger indefinite delivery contract vehicle and represents a child contract action. Cepheid, a leading manufacturer of molecular diagnostic systems and reagents, provides the GeneXpert diagnostic...
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $5,775 to Cepheid Inc. for diagnostic testing supplies under a larger indefinite delivery contract framework. This firm fixed-price delivery order, designated XPRS-COV2-10, was awarded on January 16, 2026, with an ultimate completion date of January 26, 2026, and is not subject to any small business set-aside designation. The order calls for delivery to Cepheid's headquarters location in Sunnyvale,...
- The Defense Logistics Agency Medical Supply Chain awarded a $40.8K delivery order to Cepheid Inc. on January 27, 2026, for molecular diagnostic reagents and test kits under the XPRS4PLEX-10 contract vehicle. This delivery order, which is a child contract with a firm fixed-price structure and no set-aside designation, is scheduled for completion by February 3, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. The award represents continued procurement of diagnostic...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $27,200 to Cepheid Inc. on January 15, 2026, for diagnostic reagents and test kits under an existing Indefinite Delivery Contract framework. This firm fixed-price delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 23, 2026, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The contract carries no set-aside designation, reflecting Cepheid's...
- The Defense Logistics Agency Medical Supply Chain awarded a $19,645.20 delivery order to Cepheid Inc. on January 28, 2026, for molecular diagnostic testing supplies and reagents under a firm fixed-price contract type with an ultimate completion date of February 4, 2026. This delivery order, identified as XPRS4PLEX-10, represents a child contract with no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. The award leverages Cepheid's established...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 8, 2025, with an ultimate completion date of December 15, 2025. This delivery order, designated XPRS4PLEX-10, represents a small procurement of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal...
- This delivery order, valued at $40,800, was awarded to Cepheid Inc. on December 22, 2025, by the Defense Logistics Agency Medical Supply Chain for molecular diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The order is firm fixed-price with no set-aside designation and is scheduled for completion by December 30, 2025. As the prime contractor, Cepheid will deliver diagnostic reagents and test kits designed for its GeneXpert diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,840.00 under contract XPRSTREPA-10 by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of December 31, 2025, represents a task order under an existing Indefinite Delivery Contract vehicle. The award is for diagnostic reagents and test kits designed for Cepheid's GeneXpert diagnostic platform,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,530.08 to Cepheid Inc. on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a relatively modest procurement within Cepheid's broader federal contract portfolio. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier. Performance will take place at...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F36RDDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $14,285.20 delivery order to Cepheid Inc. on January 30, 2026, for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by February 6, 2026, and represents a child order under a larger indefinite delivery contract vehicle. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and reagents specializing in infectious disease detection, including COVID-19, influenza, respiratory syncytial virus, and other respiratory pathogens. The award includes no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement market. This delivery order supports the Defense Logistics Agency's medical supply chain operations, which procure diagnostic testing supplies for Department of Defense healthcare facilities and military medical centers. Cepheid maintains an extensive federal contract portfolio with multiple agencies, including substantial indefinite delivery contracts with the Department of Veterans Affairs valued at over $39 million through 2030, as well as ongoing contracts with the Defense Health Agency, Indian Health Service, and U.S. Coast Guard. The company's GeneXpert diagnostic platform and associated molecular testing capabilities have established Cepheid as a primary federal supplier of diagnostic solutions across the military healthcare system and broader federal government health agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 1/29/26 |